Arkolith/Insider Trading/CRSP/Form 4

Kulkarni Samarth

Chief Executive Officer, DirectorCRISPR Therapeutics AG (CRSP) · full profile →Form 4 · filed Feb 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$366K
Net Open-Market Flow
-$366K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 19, 2026Sell(S)7K$52.58$366K226K
Feb 18, 2026Option exercise(M)13K——233K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 18, 2026Option exercise(M)13K——0

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-061712) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML